Registrant profile
Taizhou Zecen Biotech Co., Ltd.
泰州泽成生物技术有限公司
Jiangsu·China NMPA·234 registered devices
234
Total devices
2
Device classes
2017
Earliest approval
2024
Latest approval
Company overview
- Total devices
- 234
- Province/Region
- Jiangsu江苏
- Address
- Taizhou City, China Medicine City Kou Tai Road, east side of G59 Building No. 62 west half of the west side of the first to fourth floors泰州市中国医药城口泰路西侧、陆家路东侧G59幢62号西半侧一至四层
Registration timeline
- Earliest approval
- Jun 28, 2017
- Latest approval
- May 28, 2024
Device class distribution
Breakdown of 234 devices by regulatory classification
Class II
221
94.4% of total
Class III
13
5.6% of total
Registered devices (10 most recent shown)
Click on any device for detailed registration information
| Product name | Class | Registration number | Approval date | Expiry date | Detail |
|---|---|---|---|---|---|
S100-β蛋白测定试剂盒（化学发光免疫分析法） | Class II | 苏械注准20242401186 | May 28, 2024 | May 27, 2029 | View |
Gastrin-17 Test Kit (Chemiluminescent Magnetic Particle Method) 胃泌素17检测试剂盒（磁微粒化学发光法） | Class II | 苏械注准20242401043 | May 08, 2024 | May 07, 2029 | View |
Free Estradiol Calibration Standard 游离雌三醇校准品 | Class II | 苏械注准20232401661 | Nov 22, 2023 | Nov 21, 2028 | View |
Glycocholic Acid Calibration Standard 甘胆酸校准品 | Class II | 苏械注准20232401633 | Nov 20, 2023 | Nov 19, 2028 | View |
Cortisol calibration solution 皮质醇校准品 | Class II | 苏械注准20232401635 | Nov 20, 2023 | Nov 19, 2028 | View |
Gastrin 17 calibrator 胃泌素17校准品 | Class II | 苏械注准20232401603 | Nov 17, 2023 | Nov 16, 2028 | View |
Insulin-like growth factor-I. calibrator 胰岛素样生长因子-Ⅰ校准品 | Class II | 苏械注准20232401619 | Nov 17, 2023 | Nov 16, 2028 | View |
Anti-insulin Antibody Calibration Material 抗胰岛素抗体校准品 | Class II | 苏械注准20232401616 | Nov 17, 2023 | Nov 16, 2028 | View |
Type IV Collagen Calibration Product Ⅳ型胶原校准品 | Class II | 苏械注准20232401586 | Nov 17, 2023 | Nov 16, 2028 | View |
Total Thyroxine Calibration Product 总甲状腺素校准品 | Class II | 苏械注准20232401626 | Nov 17, 2023 | Nov 16, 2028 | View |
About this profile
Complete regulatory portfolio for Taizhou Zecen Biotech Co., Ltd. in China's medical device market. This registrant has 234 medical devices registered with China NMPA, with registrations dating from Jun 28, 2017 to May 28, 2024.
Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.